Abstract:BACKGROUND Cerebrotendinous xanthomatosis (CTX) is a treatable autosomal recessive inherited metabolic disorder. It results from a deficiency of sterol 27-hydroxylase (CYP27A1), which is a mitochondrial cytochrome P450 enzyme that catalyzes the hydroxylation of cholesterol and modulates cholesterol homeostasis. Patients with CYP27A1 deficiency show symptoms related to excessive accumulation of cholesterol and cholestanol in lipophilic tissues such as the brain, eyes, tendons, and vessels, resulting in juvenile cataracts, tendon xanthoma, chronic diarrhea, cognitive impairment, ataxia, spastic paraplegia, and peripheral neuropathy. CTX is underdiagnosed as knowledge of the disorder is mainly based on case reports. CASE SUMMARY A Chinese family with CTX consisting of one patient and four heterozygous carriers was studied. The patient is a 47-year-old male, who mainly had psychiatric signs but without some cardinal features of CTX such as cataracts, cerebellar ataxia, pyramidal signs and chronic diarrhea. There was a significant increase in the concentration of free fatty acid compared to normal range. Doppler ultrasound of the urinary system showed multiple left kidney stones, a right kidney cyst, and a hypoechoic area in the bladder, which could move with body position. Sagittal and axial magnetic resonance imaging (MRI) of the right ankle joint showed apparent enlargement of the right Achilles tendon and upper medial malleolus flexor tendon, abnormal thickening of the plantar fat, and a small amount of exudation around the fascia in front of the Achilles tendon. Cerebral MRI suggested white matter (WM) demyelination and slight cerebral atrophy. The diagnosis was confirmed by targeted sequencing, which identified compound heterozygous mutations in exon 2 and intron 7 of the CYP27A1 gene (c.435G>T, c.1263+1G>A). Treatment for 3 wk with a combination of lipid-lowering and antipsychotic therapy improved his psychiatric symptoms and normalized the levels of serum free fatty acid. Sediments in the bladder disappeared after therapy. CONCLUSION CYP27A1 genetic analysis should be the definitive method for CTX diagnosis. This case suggests that urinary system diseases may be neglected in CTX patients. The clinical, biological, radiological, and genetic characteristics of CTX are summarized to promote early diagnosis and treatment of this disease.

Corneal cystine crystals in cystinosis

Homocystinuria In A Family With Novel Cystathionine Beta Synthase Gene Mutations

CTNS gene mutation leads to cysteine nephropathy combined with corneal crystal in young child

A novel gammaD-crystallin mutation causes mild changes in protein properties but leads to congenital coralliform cataract.

Clinical, Biochemical, and Genetic Findings of Cystinuria in Chinese Children.

Ocular Involvement in Patients with Infantile Nephropathic Cystinosis

Cystinosis induced by CTNS gene mutation: a rare disease study

Digenetic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome

Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

The clinical and genetic findings of childhood cystinuria

Clinical Characteristics and In Silico Analysis of Cystinuria Caused by a Novel SLC3A1 Mutation

Intermediate cystinosis: a case report of 10-year treatment with cysteamine

Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis

Medullary nephrocalcinosis in nephropathic cystinosis

A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability

Evaluation of a new classification system for measuring the progression of ocular cystinosis: an analysis of 64 patients

Case Report and Literature Review: A De Novo Pathogenic Missense Variant in ACTN4 Gene Caused Rapid Progression to End-Stage Renal Disease

Cortical impairment and reduced muscle mass in children and young adults with nephropathic cystinosis

Autosomal Dominant Coralliform Cataract Related to a Missense Mutation of the Gammad-Crystallin Gene.

Cystinuria: mechanisms and management

Declaration: Novel SLC3A1 Mutation in a Cystinuria Patient with Xanthine Stones: a Case Report